ADENOCARCINOMA OF UNKNOWN PRIMARY ORIGIN - IMPACT OF CHEMOTHERAPY ON SURVIVAL

被引:0
|
作者
INDUPALLI, SR
BEDIKIAN, AY
BODEY, GP
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1431 / 1435
页数:5
相关论文
共 50 条
  • [21] Melanoma of Unknown Primary Origin: Decreased Survival for Stage 4 Patients
    Rushing, E. C.
    Tuthill, R.
    LABORATORY INVESTIGATION, 2011, 91 : 124A - 124A
  • [22] The Impact of Molecular Testing on Treatment of Cancer of Unknown Primary Origin
    Greco, F. Anthony
    ONCOLOGY-NEW YORK, 2013, 27 (08): : 815 - 817
  • [23] Left Axilla Adenocarcinoma of Unknown Origin
    Jiang, Heng
    Lele, Subodh M.
    Santamaria-Barria, Juan A.
    JAMA ONCOLOGY, 2023, 9 (05) : 710 - 711
  • [24] TREATMENT OF PATIENT WITH ADENOCARCINOMA OF UNKNOWN ORIGIN
    MOERTEL, CG
    REITEMEIER, RJ
    SCHUTT, AJ
    HAHN, RG
    CANCER, 1972, 30 (06) : 1469 - 1472
  • [25] FEVER OF UNKNOWN ORIGIN AND ADENOCARCINOMA OF COLON
    HERNANDEZ, FJB
    DERIVERA, JMPS
    RODRIGUEZ, JJV
    MEDICINA CLINICA, 1995, 105 (02): : 79 - 79
  • [26] Impact of neoadjuvant chemotherapy on nodal regression and survival in oesophageal adenocarcinoma
    Evans, Richard P. T.
    Kamarajah, Sivesh K.
    Kunene, Victoria
    Zardo, Davide
    Elshafie, Mona
    Griffiths, Ewen A.
    EJSO, 2022, 48 (05): : 1001 - 1010
  • [27] ADENOCARCINOMA WITH UNKNOWN PRIMARY LOCALIZATIONS
    GAGNERIE, F
    SEMAINE DES HOPITAUX, 1987, 63 (23): : 1889 - 1890
  • [28] METASTATIC ADENOCARCINOMA OF UNKNOWN PRIMARY SITE - ABNORMALITIES OF CELLULAR DNA CONTENT AND SURVIVAL
    HEDLEY, DW
    LEARY, JA
    KIRSTEN, F
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (02): : 185 - 189
  • [29] Comment on: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
    Liu, Kai
    Zhang, Wei-han
    Hu, Jian-kun
    BRITISH JOURNAL OF SURGERY, 2022, 109 (08) : E91 - E91
  • [30] Risk factors and predictors for tumor site origin in metastatic adenocarcinoma of unknown primary site
    Li, Xinrong
    Shao, Yan
    Sheng, Liqiang
    Zhu, Junquan
    Wang, Zeming
    Guo, Kaibo
    Sun, Leitao
    CANCER MEDICINE, 2021, 10 (03): : 974 - 988